Delivery Order SPE2DB20D3103-SPE2DB26FL5N1
- Not listed
- The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,712.87 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quviviq 25 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,877.08 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Quivivq 50 mg tablets (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30s. This is a firm fixed price delivery order with a ceiling value of $1,662.22, representing a non-set-aside competitive award. The contract has an ultimate completion date of November 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,081.69 Firm Fixed Price Delivery Order is for the supply of 4566178485 QUVIVIQ 50 MG TABLET 30S, with a period of performance through October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QUVIVIQ 25 MG TABLET 30S. The contract has a firm fixed price of $1,027.28 and a performance period through June 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a $369,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50mg Quviviq tablets. Under this order, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania by September 19, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, suggesting this order supports medical supplies for DOD operations. No set...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,692.28 Delivery Order contract is for the supply of the medication QUVIVIQ 50 MG TABLET 30S, with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $1,264.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product, with a performance period ending on March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5N1Delivery Order
The Defense Logistics Agency awarded a $1,115.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Quviviq 50 mg tablets (30-count). The contract, which is scheduled for completion by November 12, 2025, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's medical supply chain, supporting military healthcare systems and other federal health programs. The company's DLA prime contract vehicle enables the supply of a comprehensive range of pharmaceutical products and medical commodities across multiple therapeutic domains. This delivery order for Quviviq, a prescription medication, exemplifies the routine pharmaceutical procurement activities executed under the broader IDC framework to support ongoing military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/10/25 |